AMRI Buys Spanish API Maker Gadea | Chemical & Engineering News
Volume 93 Issue 29 | p. 17 | Concentrates
Issue Date: July 20, 2015

AMRI Buys Spanish API Maker Gadea

Department: Business
Keywords: pharmaceutical chemicals, APIs, Spain

The contract research and manufacturing firm Albany Molecular Research Inc. has acquired Gadea Pharmaceutical, a Spanish maker of active pharmaceutical ingredients (APIs) and finished drugs, for $174 million. Gadea, which had sales last year of $83 million, produces complex APIs including steroids and hormones in its Crystal Pharma division. Two other divisions make finished-dose drugs. AMRI says the deal enhances its complex API offerings and its global reach. AMRI’s last move into Europe was the 2010 purchase of an API plant in Wales, but the firm is now in the process of closing it.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment